American Portfolios Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $378K | Sell |
12,831
-12
| -0.1% | -$353 | 0.02% | 758 |
|
|
2022
Q2 | $699K | Sell |
12,843
-695
| -5% | -$37.8K | 0.03% | 539 |
|
|
2022
Q1 | $737K | Buy |
13,538
+2,072
| +18% | +$113K | 0.03% | 581 |
|
|
2021
Q4 | $632K | Buy |
11,466
+2,440
| +27% | +$134K | 0.02% | 638 |
|
|
2021
Q3 | $431K | Sell |
9,026
-45
| -0.5% | -$2.15K | 0.02% | 767 |
|
|
2021
Q2 | $452K | Sell |
9,071
-494
| -5% | -$24.6K | 0.02% | 757 |
|
|
2021
Q1 | $427K | Sell |
9,565
-673
| -7% | -$30K | 0.02% | 718 |
|
|
2020
Q4 | $471K | Sell |
10,238
-580
| -5% | -$26.7K | 0.02% | 574 |
|
|
2020
Q3 | $509K | Sell |
10,818
-496
| -4% | -$23.3K | 0.03% | 480 |
|
|
2020
Q2 | $577K | Buy |
11,314
+187
| +2% | +$9.53K | 0.04% | 401 |
|
|
2020
Q1 | $527K | Buy |
11,127
+196
| +2% | +$9.28K | 0.04% | 355 |
|
|
2019
Q4 | $642K | Buy |
10,931
+375
| +4% | +$22K | 0.05% | 360 |
|
|
2019
Q3 | $563K | Buy |
10,556
+1,190
| +13% | +$63.5K | 0.05% | 363 |
|
|
2019
Q2 | $469K | Buy |
9,366
+53
| +0.6% | +$2.65K | 0.04% | 413 |
|
|
2019
Q1 | $486K | Buy |
9,313
+1,719
| +23% | +$89.8K | 0.05% | 377 |
|
|
2018
Q4 | $363K | Sell |
7,594
-1,500
| -16% | -$71.6K | 0.04% | 361 |
|
|
2018
Q3 | $457K | Sell |
9,094
-752
| -8% | -$37.8K | 0.05% | 342 |
|
|
2018
Q2 | $496K | Buy |
9,846
+628
| +7% | +$31.6K | 0.07% | 283 |
|
|
2018
Q1 | $450K | Buy |
9,218
+2,304
| +33% | +$113K | 0.07% | 284 |
|
|
2017
Q4 | $307K | Buy |
+6,914
| New | +$307K | 0.05% | 364 |
|